Track topics on Twitter Track topics that are important to you
Each new technology has a story behind it. On Dec. 5, our Xchange Forum will offer a behind-the-scenes look at how some of them aim to transform healthcare. Xconomy’s San Francisco Biotech: The Next...
Cortexyme, Inc., a clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s disease (AD) and other degenerative diseases, announced the f...
-- Data on safety and exploratory cognitive testing presented in late-breaking poster at the 2018 Clinical Trials of Alzheimer’s Disease Conference -- Phase 2 en...
Based in South San Francisco, California, Cortexyme is a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimerâs and ...
We have published hundreds of Cortexyme, Inc. news stories on BioPortfolio along with dozens of Cortexyme, Inc. Clinical Trials and PubMed Articles about Cortexyme, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cortexyme, Inc. Companies in our database. You can also find out about relevant Cortexyme, Inc. Drugs and Medications on this site too.
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...